StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2020 it was -$4.35M.

Annual operating income

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$4.35M–
FY2019Dec 31, 2019-$6.46M–
FY2017Dec 31, 2017-$7.05M–

More Quoin Pharmaceuticals figures

See a number that looks wrong?